Oculis Holding AG

OCSNASDAQ · USD
10.31USD-0.40 (-3.74%)
235

Oculis Holding AG (OCS) Option Chain

As of September 22, 2026, Oculis Holding AG is trading at $10.31, a -3.74% change from the previous close. The nearest expiration is Oct 16, 2026. Implied volatility is 98.3%. IV Rank is —%.

Read more

Tracking the OCS option chain helps you see every strike and expiry on Oculis Holding AG in one view, so you can quickly identify the contracts that fit your thesis and your risk. Oculis Holding AG's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of OCS options activity at a glance. Use our scanner to monitor the OCS option chain in real time and filter for the OCS options trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For OCS stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the OCS option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where OCS stock options are being actively traded and where they are not.

Oculis Holding AG, a clinical-stage biopharmaceutical company, develops novel topical treatments for ophthalmic diseases for both back- and front-of-the-eye. The company's lead candidate is OCS-01, a topical dexamethasone formulation, which is in Phase 3 clinical trials for the treatment of diabetic macular edema; OCS-02, a topical biologic candidate that is in Phase 2b clinical trials for the treatment for keratoconjunctivitis sicca, or dry eye disease; and OCS-05, a novel neuroprotective agent for acute optic neuritis and other neuro-ophtha disorders, such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.

The company is based in Zug, Switzerland.

Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Oculis Holding AG's full chain across every expiry, highlights the most liquid strikes, and lets you screen OCS options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of OCS stock options — let the full option chain come to you, pre-filtered and ready to trade.

Stock Statistics

  • IndustryBiotechnology
  • SectorHealthcare
  • IV percentile
  • Market cap (M$)660
  • 52 weeks high-68.94%
  • 52 weeks low10.98%
  • Analyst recommendationStrong Buy
    1.09
  • Target price$36.70
    250.82% above the current stock price
  • Dividend
  • Payout ratio
  • Earnings date2026-11-05
  • P/E
  • Future P/E
  • EPS (ttm)-1.76
  • EPS growth next 5 years9.57%

As of September 22, 2026

2026-10-16
5 strikes
Default
CALLsPUTs
Prob. OTM %Open InterestVolumeExtrinsic ValueIntrinsic ValueBidAskStrikeMoneyness %BidAskIntrinsic ValueExtrinsic ValueVolumeOpen InterestProb. OTM %
0.17000.395.313.507.905.00-53.314.900.004.900099.83
9.54000.342.811.005.307.50-29.974.900.004.900090.46
43.6858102.190.312.5010.00-6.634.900.004.900056.32
76.80000.280.000.050.5012.50+16.710.204.902.190.360123.20
92.791100.100.000.1015.00+40.062.206.504.69-0.34007.21

As of September 22, 2026

Scan the full option chain in one place

Browse the full OCS option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.

Start your 14-day free trial